
News|Articles|November 10, 2025
An approach to streamline and simplify the identification of crucial metabolites from targeted protein degraders
Author(s)SCIEX
The identification of drug metabolites is a critical step in drug development due to their impact on drug efficacy and safety. LC-MS platforms provide good selectivity and sensitivity making it the preferred technique for metabolite identification. Here, metabolite identification was performed using unique fragments from EAD and CID spectra. Fragment information from EAD and CID spectra were processed in a single result file to achieve confident structure assignment of and localization of metabolites.
Trending on Pharmaceutical Technology
1
Peptide Compounding Vote Raises New Questions for Drug Developers
2
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
3
Q&A : Brent Wilhelm on Supply Chains and Historical Demand Data
4
Brent Wilhelm on Cold Chain Pharmaceuticals Reshaping Shipping Needs
5